Form 8-K - Current report:
SEC Accession No. 0001171843-17-003361
Filing Date
2017-05-30
Accepted
2017-05-30 07:57:19
Documents
3
Period of Report
2017-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_053017.htm 8-K 28519
2 EXHIBIT 10.1 exh_101.htm EX-10.1 152982
3 EXHIBIT 99.1 exh_991.htm EX-99.1 5128
  Complete submission text file 0001171843-17-003361.txt   187992
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 17875635
SIC: 2836 Biological Products, (No Diagnostic Substances)